SG Americas Securities’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-17,261
| Closed | -$119K | – | 3225 |
|
2025
Q1 | $119K | Sell |
17,261
-6,596
| -28% | -$45.5K | ﹤0.01% | 2590 |
|
2024
Q4 | $127K | Buy |
23,857
+7,117
| +43% | +$37.9K | ﹤0.01% | 2269 |
|
2024
Q3 | $61K | Buy |
+16,740
| New | +$61K | ﹤0.01% | 2835 |
|
2024
Q2 | – | Sell |
-15,423
| Closed | -$54K | – | 2901 |
|
2024
Q1 | $54K | Buy |
+15,423
| New | +$54K | ﹤0.01% | 2424 |
|
2021
Q4 | – | Sell |
-20,487
| Closed | -$128K | – | 3415 |
|
2021
Q3 | $128K | Buy |
+20,487
| New | +$128K | ﹤0.01% | 3269 |
|
2021
Q2 | – | Sell |
-11,802
| Closed | -$110K | – | 2906 |
|
2021
Q1 | $110K | Buy |
+11,802
| New | +$110K | ﹤0.01% | 2765 |
|
2020
Q3 | – | Sell |
-22,300
| Closed | -$102K | – | 2991 |
|
2020
Q2 | $102K | Buy |
+22,300
| New | +$102K | ﹤0.01% | 2921 |
|
2016
Q4 | – | Sell |
-28,382
| Closed | -$85K | – | 2989 |
|
2016
Q3 | $85K | Buy |
+28,382
| New | +$85K | ﹤0.01% | 2747 |
|